首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Efficacy of combining insulin glulisine with basal insulin glargine in patients with Type 1 diabetes in everyday clinical practice
被引:0
|
作者
:
Fiesselmann, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Sanofi Aventis Deutschland GmbH, Berlin, Germany
Fiesselmann, A.
Landgraf, W.
论文数:
0
引用数:
0
h-index:
0
机构:
Sanofi Aventis Deutschland GmbH, Berlin, Germany
Sanofi Aventis Deutschland GmbH, Berlin, Germany
Landgraf, W.
[
1
]
Schreiber, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Diabet Ctr Schreiber, Quickborn, Germany
Sanofi Aventis Deutschland GmbH, Berlin, Germany
Schreiber, S.
[
2
]
机构
:
[1]
Sanofi Aventis Deutschland GmbH, Berlin, Germany
[2]
Diabet Ctr Schreiber, Quickborn, Germany
来源
:
DIABETIC MEDICINE
|
2008年
/ 25卷
关键词
:
D O I
:
暂无
中图分类号
:
R5 [内科学];
学科分类号
:
1002 ;
100201 ;
摘要
:
P43
引用
收藏
页数:1
相关论文
共 50 条
[1]
Combining insulin glulisine with basal insulin glargine provides improved glycaemic control in patients with Type 2 diabetes in everyday clinical practice
Donaubauer, B.
论文数:
0
引用数:
0
h-index:
0
机构:
Sanofi Aventis Deutschland GmbH, Berlin, Germany
Donaubauer, B.
Ferlinz, K.
论文数:
0
引用数:
0
h-index:
0
机构:
Sanofi Aventis Deutschland GmbH, Berlin, Germany
Sanofi Aventis Deutschland GmbH, Berlin, Germany
Ferlinz, K.
Schreiber, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Diabet Ctr Schreiber, Quickborn, Germany
Sanofi Aventis Deutschland GmbH, Berlin, Germany
Schreiber, S.
[J].
DIABETIC MEDICINE,
2008,
25
[2]
Efficacy of combining insulin glulisine with basal insulin glargine in patients with type I and type 2 diabetes previously on premix insulin therapy
Schreiber, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Sanofi Aventis Deutsch GmbH, Berlin, Germany
Schreiber, S.
Ferlinz, K.
论文数:
0
引用数:
0
h-index:
0
机构:
Sanofi Aventis Deutsch GmbH, Berlin, Germany
Ferlinz, K.
Donaubauer, B.
论文数:
0
引用数:
0
h-index:
0
机构:
Sanofi Aventis Deutsch GmbH, Berlin, Germany
Donaubauer, B.
[J].
DIABETOLOGIA,
2007,
50
: S410
-
S411
[3]
Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus: Using insulin glargine as basal insulin
Kawamori, Ryuzo
论文数:
0
引用数:
0
h-index:
0
Kawamori, Ryuzo
Kadowaki, Takashi
论文数:
0
引用数:
0
h-index:
0
Kadowaki, Takashi
Ishii, Hitoshi
论文数:
0
引用数:
0
h-index:
0
Ishii, Hitoshi
Iwasaki, Manabu
论文数:
0
引用数:
0
h-index:
0
Iwasaki, Manabu
Iwamoto, Yasuhiko
论文数:
0
引用数:
0
h-index:
0
Iwamoto, Yasuhiko
[J].
DIABETES,
2008,
57
: A573
-
A573
[4]
Introduction of insulin glulisine in combination with insulin glargine to basal-bolus therapy improves metabolic control in patients with type 1 diabetes in everyday clinical practice
Ruhnau, Klaus-Juergen
论文数:
0
引用数:
0
h-index:
0
Ruhnau, Klaus-Juergen
[J].
DIABETES,
2006,
55
: A479
-
A479
[5]
Efficacy and safety of insulin glulisine and insulin lispro combined with insulin glargine in patients with Type 1 diabetes
Prager, R
论文数:
0
引用数:
0
h-index:
0
机构:
Lainz Hosp, Vienna, Austria
Prager, R
Dreyer, M
论文数:
0
引用数:
0
h-index:
0
机构:
Lainz Hosp, Vienna, Austria
Dreyer, M
Robinson, A
论文数:
0
引用数:
0
h-index:
0
机构:
Lainz Hosp, Vienna, Austria
Robinson, A
Busch, K
论文数:
0
引用数:
0
h-index:
0
机构:
Lainz Hosp, Vienna, Austria
Busch, K
Penfornis, A
论文数:
0
引用数:
0
h-index:
0
机构:
Lainz Hosp, Vienna, Austria
Penfornis, A
Souhami, E
论文数:
0
引用数:
0
h-index:
0
机构:
Lainz Hosp, Vienna, Austria
Souhami, E
[J].
DIABETOLOGIA,
2004,
47
: A301
-
A301
[6]
Introduction of insulin glulisine in combination with insulin glargine to basal-bolus therapy improves metabolic control in patients with type 2 diabetes in everyday clinical practice
Bernd, Donaubauer
论文数:
0
引用数:
0
h-index:
0
Bernd, Donaubauer
[J].
DIABETES,
2006,
55
: A480
-
A480
[7]
Efficacy of Insulin Glargine Plus 1 Injection of Insulin Glulisine in Patients with Type 2 Diabetes Inadequately Controlled by Insulin Glargine
Charpentier, Guillaume
论文数:
0
引用数:
0
h-index:
0
Charpentier, Guillaume
[J].
DIABETES,
2014,
63
: A237
-
A237
[8]
Insulin Analogues Insulin Glargine and Insulin Glulisine in Type 1 Diabetes
Schreiber, S. A.
论文数:
0
引用数:
0
h-index:
0
机构:
Diabet Ctr Schreiber, Hamburg, Germany
Sanofi Aventis Deutschland GmbH, Global Diabet Div, D-65926 Frankfurt, Germany
Schreiber, S. A.
Fiesselmann, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Sanofi Aventis Deutschland GmbH, Global Diabet Div, D-65926 Frankfurt, Germany
Fiesselmann, A.
Bornstein, S. R.
论文数:
0
引用数:
0
h-index:
0
机构:
Tech Univ Dresden, Dept Med 3, Dresden, Germany
Sanofi Aventis Deutschland GmbH, Global Diabet Div, D-65926 Frankfurt, Germany
Bornstein, S. R.
Landgraf, W.
论文数:
0
引用数:
0
h-index:
0
机构:
Sanofi Aventis Deutschland GmbH, Global Diabet Div, D-65926 Frankfurt, Germany
Tech Univ Dresden, Dept Med 3, Dresden, Germany
Sanofi Aventis Deutschland GmbH, Global Diabet Div, D-65926 Frankfurt, Germany
Landgraf, W.
[J].
DIABETES STOFFWECHSEL UND HERZ,
2011,
20
(02):
: 69
-
77
[9]
Efficacy and safety of insulin glulisine(GLU) and insulin lispro (IL), combined with insulin glargine (GLAR) in patients with type 1 diabetes
Dreyer, M
论文数:
0
引用数:
0
h-index:
0
Dreyer, M
Prager, R
论文数:
0
引用数:
0
h-index:
0
Prager, R
Robinson, A
论文数:
0
引用数:
0
h-index:
0
Robinson, A
Busch, K
论文数:
0
引用数:
0
h-index:
0
Busch, K
Souhami, E
论文数:
0
引用数:
0
h-index:
0
Souhami, E
[J].
DIABETES,
2004,
53
: A123
-
A123
[10]
Efficacy and Safety of a Basal-Plus Regimen of Insulin Glargine Plus Insulin Glulisine in Patients With Type 2 Diabetes: A Pooled Analysis of 4 Clinical Trials
Del Prato, Stefano
论文数:
0
引用数:
0
h-index:
0
Del Prato, Stefano
Lankisch, Mark
论文数:
0
引用数:
0
h-index:
0
Lankisch, Mark
Lin, Jay
论文数:
0
引用数:
0
h-index:
0
Lin, Jay
Wang, Edward
论文数:
0
引用数:
0
h-index:
0
Wang, Edward
Owens, David R.
论文数:
0
引用数:
0
h-index:
0
Owens, David R.
[J].
DIABETES,
2012,
61
: A297
-
A297
←
1
2
3
4
5
→